New York Oncology Hematology, PC at Albany Medical Center

Albany, New York 12208

Use our guide to learn which trials are right for you!

We've found
5 trials
at this facility
Oncology Clinical Trial
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
New York Oncology Hematology, PC at Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
New York Oncology Hematology, PC at Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
Status: Enrolling, Phase III
Updated: 12/31/1969
New York Oncology Hematology, PC at Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
New York Oncology Hematology, PC at Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
New York Oncology Hematology, PC at Albany Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials